Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$8.02 - $8.67 $15,791 - $17,071
-1,969 Reduced 15.79%
10,498 $89,000
Q4 2023

Feb 14, 2024

SELL
$7.78 - $8.62 $111,907 - $123,990
-14,384 Reduced 53.57%
12,467 $102,000
Q3 2023

Nov 13, 2023

SELL
$7.85 - $8.94 $25,708 - $29,278
-3,275 Reduced 10.87%
26,851 $223,000
Q2 2023

Aug 11, 2023

SELL
$8.04 - $9.0 $4,116 - $4,608
-512 Reduced 1.67%
30,126 $252,000
Q1 2023

May 15, 2023

BUY
$7.57 - $8.37 $15,427 - $17,058
2,038 Added 7.13%
30,638 $249,000
Q4 2022

Feb 14, 2023

BUY
$5.96 - $8.06 $170,456 - $230,516
28,600 New
28,600 $228,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Quadrant Private Wealth Management, LLC Portfolio

Follow Quadrant Private Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Private Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Private Wealth Management, LLC with notifications on news.